ABT240726C120000
- 0.02
- -0.01-33.33%
Abbott Laboratories Newsroom
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT)
Nephron Adjusts Price Target on Abbott Laboratories to $110 From $115
Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects
Buy Rating Affirmed on Abbott Laboratories Amid Strong Q2 Results and Raised 2024 Guidance
Buy Rating Affirmed for Abbott Laboratories Amid Strong Financials and Growth Potential
Abbott Laboratories (ABT) Gets a Hold From Morgan Stanley
Buy Rating Affirmed for Abbott Laboratories Amidst Strong Growth and Manageable Risks
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $118 From $121
Abbott Laboratories Analyst Ratings
Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $125, Maintains Outperform Rating
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Springworks Therapeutics (SWTX)
Barclays Keeps Their Buy Rating on Abbott Laboratories (ABT)
Abbott Laboratories Analyst Ratings
Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115
Abbott Laboratories Analyst Ratings
Optimistic Buy Rating for Abbott Laboratories on Diverse Portfolio and Growth Prospects
Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know
Abbott Laboratories Analyst Ratings
Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating